As both epidermal growth factor receptor (EGFR) activation and ERK1/2 signal pathway are instrumental in psoriasis (Krueger et al., 1990; Johansen et al., 2005), we examined whether EGFR and ERK1/2 activation regulate PKM2 functions in keratinocytes. Here, MAPK3 is linked to psoriasis.